INO Positive Sentiment
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
Thursday, October 23, 2025 BiopharmaWatch Research 1 min read Key Takeaway: INOVIO Pharmaceuticals will participate in the Stephens Biotechnology Virtual Fireside Chat Conference on November 4, 2025. The event will feature members of INOVIO's management team engaging in one-on-one meetings with investors. This initiative underscores INOVIO's focus on developing DNA medicines for HPV-related diseases and other conditions.
Full Press Release Details
PLYMOUTH MEETING, Pa.,Oct. 23, 2025/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside chat at the upcoming Stephens Biotechnology Virtual Fireside Chat Conference. During the conference, members of INOVIO's management team will also be conducting one-on-one meetings with investors.
Date:November 4, 2025Time:3:00-3:50pm ETFormat:Virtual fireside chat
There will not be a replay or transcript of the call(s). To join the meetings or to obtain more information, please contact your Stephens representative.
About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visitwww.inovio.com.
ContactsMedia: Jennie Willson, (267) 429-8567,[email protected]Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505,[email protected]